Patients from rural settings in FG suffer from a delay in AV administration after SB envenoming leading to an extended time in which patients are coagulopathic. Once AV is administered, clotting parameters recover at a similar rate. Supplying remote healthcare facilities with AV and with medical teams trained on its use should be planned.
No takes yet. Share an insight, caveat, or question.
Houcke et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: